Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.25.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Collaboration revenue $ 1,000,000 $ 18,626
Operating expenses:    
Research and development 1,886,076 644,042
General and administrative 1,963,346 653,455
Total operating expenses 3,849,422 1,297,497
Loss from operations (2,849,422) (1,278,871)
Foreign exchange (loss) gain (152,884) 110,362
Loss before provision from income taxes (3,002,306) (1,168,509)
Provision for income taxes (158,400)
Net loss $ (3,160,706) $ (1,168,509)
Per share information:    
Net loss per share, basic $ (1.56) $ (2.46)
Net loss per share, diluted $ (1.56) $ (2.46)
Weighted average shares outstanding, basic 2,022,818 474,699
Weighted average shares outstanding, diluted 2,022,818 474,699